Source: GlobalNewswire

Followers on Owler

167

Annual Revenue

$25-100M

Employees

100-250

President & CEO

Jay S. Duker

CEO Approval Rating

82/100

EyePoint is a Massachusetts-based pharmaceutical company that discovers and develops ophthalmic therapeutics for the treatment of eye disorders.

EyePoint received $161M in Post-IPO Equity Funding